Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19 Overview Pfizer Inc. and BioNTech SE have announced positive topline results from a Phase 1/2 study evaluating the safety, tolerability, and immune responses of their mRNA-based combination vaccine candidates for influenza and COVID-19. The study demonstrated robust immune responses […]
The Impact of Disaster on the Pharmaceutical Industry: The Unforeseen Consequences of Natural Disasters on Pfizer and the Supply Chain Introduction: Natural disasters have the potential to cause widespread damage and disruption to various industries, and the pharmaceutical sector is no exception. The recent tornado damage that struck a Pfizer facility brings attention to the […]
The Fallout from a Tornado at Pfizer Plant Could Worsen Drug Shortages at U.S. Hospitals A recent tornado that damaged a Pfizer factory in Rocky Mount, North Carolina, has raised concerns about the already-strained drug supplies in U.S. hospitals. The factory, which produces approximately 25% of all sterile injectable medicines used in American hospitals, suffered […]
